| Citation: |
WEIYu-jian, LOUBin, WANGXin-dong. Preparation of BaohuosideⅠ-loaded Mixed Micelles and Its Anti-tumor Activity[J]. Journal of Nanjing University of traditional Chinese Medicine, 2016, 32(1): 62-66.
|
| [1] |
Qian Q， Li SL， Sun E， et al. Metabolite profiles of icariin in rat plasma by ultra-fast liquid chromatography coupled to triple-quadrupole/time-of-flight mass spectrometry[J]. J Pharm Biomed Anal， 2012， 66:392-398.
|
| [2] |
Zhai YK， Guo X， Pan YL， et al. A systematic review of the efficacy and pharmacological profile of Herba Epimedii in osteoporosis therapy[J]. Pharmazie， 2013， 68(9): 713-722.
|
| [3] |
Yu XB， Tong Y， Han XQ， et al. Anti-angiogenic activity of Herba Epimedii on zebrafish embryos in vivo and HUVECs in vitro[J]. Phytother Res， 2013， 27(9): 1368-1375.
|
| [4] |
Xiao HH， Fung CY， Mok SK， et al. Flavonoids from Herba epimedii selectively activate estrogen receptor alpha (ER alpha) and stimulate ER-dependent osteoblastic functions in UMR-106 cells[J]. J Steroid Biochem， 2014， 143: 141-151.
|
| [5] |
Song J， Shu L， Zhang ZH， et al. Reactive Oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer[J]. Chem Biol Interact， 2012， 199(1): 9-17.
|
| [6] |
Kim SH， Ahn KS， Jeong SJ， et al. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells[J]. Eur J Pharmacol， 2011， 654(1): 10-16.
|
| [7] |
Choi HJ， Eun JS， Kim DK， et al. Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1 alpha in human osteosarcoma cells[J]. Eur J Pharmacol， 2008， 579(1/3): 58-65.
|
| [8] |
Jin X， Zhang ZH， Sun E， et al. Preparation of a nanoscale baohuosideⅠ- phospholopid complex and determination of its absoption: in vivo and in vitro evaluations[J]. Int J Nanomed， 2012， 7: 4907-4916.
|
| [9] |
Liu YQ， Yang QX， Cheng MC， et al. Synergistic inhibitory effect of Icariside II with Icaritin from Herba Epimedii on pre-osteoclastic RAW264.7 cell growth[J]. Phytomedicine， 2014， 21(12): 1633-1637.
|
| [10] |
严红梅，孙娥，宋捷，等．宝藿苷Ⅰ磷脂复合物的制备及其抗肿瘤活性的初步研究[J]．中国药学杂志，2014， 49（19）：1725-1728．
|
| [11] |
Yan HM， Sun E， Song J， et al. Physicochemical properties of baohuoside Ⅰ phytosomes and its anti-tumor activity[J]. Chin Pharm J， 2014， 49(19): 1725-1728.
|
| [12] |
Wu WT， Shi WJ， Wu QZ. Preparation and in vitro evaluation of docetaxel-loaded solutol HS15/pluronic F127 mixed micelles[J]. Prog Phar Sci， 2013， 37(5): 222-228.
|
| [13] |
崔亚男，葛建君，李凌冰．紫杉醇混合胶束的制备及增强口服生物利用度研究[J]．山东大学学报:医学版，2012， 50（11）：107-112．
|
| [14] |
Cui YN， Ge JJ， Li LB. Preparation of paclitaxel-loaded mixed micelles and enhancement on oral absorption of paclitaxel[J]. J Shandong Univ: Med Sci， 2012， 50(11): 107-112.
|
| [15] |
刘洁凝，刘珊珊，吴琼珠，等．多西紫杉醇前体混合胶束的制备及体外评价[J]．中国药科大学学报，2010， 41（3）：240-243．
|
| [16] |
Liu JN， Liu SS， Wu QZ， et al. Preparation and in vitro evaluation of pro-mixed docetaxel micelles[J]. J China Pharm Univ， 2010， 41(3): 240-243.
|
| [17] |
Illum L， Jordan F， Lewis AL. CriticalSorb:a novel efficient nasal delivery system for human growth hormone based on Solutol HS15[J]. J Controll Release， 2012， 162(1): 194-200.
|
| [18] |
魏平平，张振海，金鑫，等．木犀草素混合胶束的制备及其抗肿瘤活性研究[J]．中国药学杂志，2015， 50（15）：1330-1334．
|
| [19] |
Wei PP， Zhang ZH， Jin X， et al. Preparation of luteolin-loaded mixed miceHes and their anti-tumor activity[J]. Chin Pharm J， 2015， 50(15): 1330-1334.
|
| [20] |
王猛，张钧寿，周建平．注射用辅料泊洛沙姆188[J]．药学与临床研究，2007， 15（1）：10-13．
|
| [21] |
Wang M， Zhang JS， Zhou JP. An injectable excipient： poloxamer 188[J]. Pharm Clin Res， 2007， 15(1): 10-13.
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: